<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00855725</url>
  </required_header>
  <id_info>
    <org_study_id>GCRC 0246</org_study_id>
    <secondary_id>08-128</secondary_id>
    <nct_id>NCT00855725</nct_id>
  </id_info>
  <brief_title>Affective Processing in Depression and Epilepsy</brief_title>
  <official_title>Affective Processing in Depression and Epilepsy; An fMRI Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwell Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to determine whether there are unique markers on neuroimaging that&#xD;
      are associated with depression in epilepsy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Symptoms of depression is commonly seen in patients with epilepsy. There are similarities and&#xD;
      differences between depressive symptoms in epilepsy when compared with primary depression.&#xD;
      Through the use of fMRI (Functional MRI), we hope to determine whether there are unique&#xD;
      markers on neuroimaging that are associated with depression in epilepsy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    PI wanted to discontinue study.&#xD;
  </why_stopped>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <enrollment type="Actual">14</enrollment>
  <condition>Epilepsy</condition>
  <condition>Depression</condition>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>fMRI</intervention_name>
    <description>Subjects will undergo MRI scanning to gather data about cognetive functions.</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hamilton Depression Rating Scale</intervention_name>
    <description>Investigator will evalute the subject during a one on one interview for depression using the Hamilton Depression Rating Scale.</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Beck's Depressive Inventory</intervention_name>
    <description>Subjects will complete self assessment to evaluate their level of depression.</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Interictal Dysphoric Disorder Inventory (IDDI)</intervention_name>
    <description>Subject will complete self assessment to determine if there have been any changes in mood, emotions and or feelings from time to time.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        There are four study groups.&#xD;
&#xD;
          1. Healthy Controls&#xD;
&#xD;
          2. Subjects with epilepsy only&#xD;
&#xD;
          3. Subjects with primary depression only&#xD;
&#xD;
          4. Subjects with epilepsy and depressive symptoms.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        For Control Group&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy adults of 18 years of age or older.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject has no history of affective disorders&#xD;
&#xD;
          -  Subject scores higher than 5 on Hamilton Depression Rating Scale&#xD;
&#xD;
          -  Subject with prior primary diagnosis of any psychotic disorder, bipolar disorder,&#xD;
             anxiety disorder, or any other serious medical or neurological disorder&#xD;
&#xD;
          -  Subject is pregnant&#xD;
&#xD;
          -  Subject is unable to undergo a MRI&#xD;
&#xD;
        Epilepsy Only Group&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject is at least 18 years of age&#xD;
&#xD;
          -  Subject has confirmed temporal lobe epilepsy (TLE)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject has a history of depression&#xD;
&#xD;
          -  Subject scores higher then 5 on Hamilton Depression Rating Scale&#xD;
&#xD;
          -  Subject with prior primary diagnosis of any psychotic disorder, bipolar disorder,&#xD;
             anxiety disorder, or any other serious medical or neurological disorder&#xD;
&#xD;
          -  Subject is pregnant&#xD;
&#xD;
          -  Subject is unable to undergo a MRI&#xD;
&#xD;
        Depression Only Group&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject is at least 18 years of age&#xD;
&#xD;
          -  Subject scores between 12 and 18 on Hamilton Depression Rating Scale&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject scores higher than 18 on Hamilton Depression Rating Scale&#xD;
&#xD;
          -  Subject is currently being medicated for depression&#xD;
&#xD;
          -  Subject has history of major depression or dysthymia&#xD;
&#xD;
          -  Subject with prior primary diagnosis of any psychotic disorder, bipolar disorder,&#xD;
             anxiety disorder, or any other serious medical or neurological disorder&#xD;
&#xD;
          -  Subject is pregnant&#xD;
&#xD;
          -  Subject is unable to undergo a MRI&#xD;
&#xD;
        Depression and Epilepsy Group&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject has confirmed temporal lobe epilepsy (TLE)&#xD;
&#xD;
          -  Subject scores between 12 and 18 on Hamilton Depression Rating Scale&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject has history of major depression or dysthymia&#xD;
&#xD;
          -  Subject is currently on medication for depression&#xD;
&#xD;
          -  Subject with prior primary diagnosis of any psychotic disorder, bipolar disorder,&#xD;
             anxiety disorder, or any other serious medical or neurological disorder&#xD;
&#xD;
          -  Subject is pregnant&#xD;
&#xD;
          -  Subject is unable to undergo a MRI&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan Ettinger, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwell Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>North Shore LIJ Health System</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <study_first_submitted>March 3, 2009</study_first_submitted>
  <study_first_submitted_qc>March 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2009</study_first_posted>
  <last_update_submitted>July 8, 2009</last_update_submitted>
  <last_update_submitted_qc>July 8, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 9, 2009</last_update_posted>
  <responsible_party>
    <name_title>Alan Ettinger, M.D.</name_title>
    <organization>Vice Chairman, Department of Neurology</organization>
  </responsible_party>
  <keyword>Epilepsy</keyword>
  <keyword>Depression</keyword>
  <keyword>Neurology</keyword>
  <keyword>fMRI</keyword>
  <keyword>Healthy Controls</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

